Tumor Microenvironment and Invasion

To promote collaborative research to understand how cancer cells interact with the surrounding tissue stroma, vasculature, and immune system, in order to develop more effective targeted treatments to inhibit cancer progression.

Developmental Cancer Therapeutics

To enable researchers to discover and develop new drugs to treat cancer. Chemotherapeutic drugs provide basic scientists with knowledge of cancer mechanisms, clinicians with weapons to treat the disease, and patients with hope. Drug development unites all who are involved in the fight against cancer.

Hematological Malignancies

To promote research collaboration in understanding the molecular pathogenesis of blood cancers in order to develop more effective and less toxic therapies for blood cancers.

Translational Program in Urological Cancers

To understand molecular mechanisms of urological malignancies with the ultimate goal of improved treatment and diagnosis. Vision for our program is based on the holistic view that integration of basic research and clinical sciences is critically important for achieving the goal.

Translational Program in Lifetime Survivorship

To identify diagnostic tools, preventative interventions, and treatment targets that can reduce morbidity, restore or maintain health, and improve quality of life in cancer survivors.